DOI: 10.1056/NEJMoa2032183 **Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al
Published online 2025
By tracking your progress, you can adjust the dosage based on your bodys response rather than relying on guesswork or trial-and-error methods
4 The burden of MASLD is projected to increase exponentially, with anticipated rises of 21% and 63% in cases of MASLD and MASH, respectively
The post hoc design, modest sample size, HIV-specific cohort, and 32-week follow-up limit generalizability
From the busy executive who needs an energy boost to the weekend warrior recovering from an intense workout, we've helped countless people find the benefits of professional IV therapy